Page last updated: 2024-08-21

cyclooctane and Neoplasms

cyclooctane has been researched along with Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Laforest, R; Läppchen, T; Robillard, MS; Rossin, R; van den Bosch, SM	1

Other Studies

1 other study(ies) available for cyclooctane and Neoplasms

Article	Year
Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:11 Topics: Animals; Antibodies, Monoclonal; Cycloaddition Reaction; Cyclooctanes; Female; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Kinetics; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Neoplasms; Radiation Dosage; Radiometry; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2013

Article

Year

Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:11

Topics: Animals; Antibodies, Monoclonal; Cycloaddition Reaction; Cyclooctanes; Female; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Kinetics; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Neoplasms; Radiation Dosage; Radiometry; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2013